SPONSOR

RenJi Hospital

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 2, Phase 3, EARLY_Phase 1

Conditions studied: Acute Pancreatitis (AP)Thrombotic Disorders Hemodialysis Access Failure Oligometastatic Prostate Cancer Breast Cancer Colorectal Carcinoma HR-positive/HER2-negative Breast Cancer Immune System and Related Disorders Breast Cancer Invasive Type 1 Primary Hyperoxaluria

RenJi Hospital is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Acute Pancreatitis (AP), Thrombotic Disorders, Hemodialysis Access Failure, Oligometastatic Prostate Cancer.

The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — RenJi Hospital

How many clinical trials has RenJi Hospital sponsored?

ClinicalMetric currently tracks 17 clinical trials sponsored by RenJi Hospital, of which 17 are actively recruiting participants. These trials cover conditions including Acute Pancreatitis (AP), Thrombotic Disorders, Hemodialysis Access Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does RenJi Hospital research focus on?

RenJi Hospital clinical trials span Acute Pancreatitis (AP), Thrombotic Disorders, Hemodialysis Access Failure, Oligometastatic Prostate Cancer, Breast Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a RenJi Hospital clinical trial?

To participate in a RenJi Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all RenJi Hospital trials with current recruitment status updated daily.

RenJi Hospital

Frequently Asked Questions — RenJi Hospital

Clinical Trials by RenJi Hospital

Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders

Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Disitamab Vedotin (RC48-ADC) in Breast Cancer

COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer

Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer

COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer

Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

ImmunoPET Imaging of Pancreatic Cancer

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)

A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis